Protein Summary
Isoform 1 functions as extracellular chaperone that prevents aggregation of nonnative proteins. Prevents stress-induced aggregation of blood plasma proteins. Inhibits formation of amyloid fibrils by APP, APOC2, B2M, CALCA, CSN3, SNCA and aggregation-prone LYZ variants (in vitro). Does not require ATP. Maintains partially unfolded proteins in a state appropriate for subsequent refolding by other chaperones, such as HSPA8/HSC70. Does not refold proteins by itself. Binding to cell surface receptors triggers internalization of the chaperone-client complex and subsequent lysosomal or proteasomal degradation. Secreted isoform 1 protects cells against apoptosis and against cytolysis by complement. Intracellular isoforms interact with ubiquitin and SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complexes and promote the ubiquitination and subsequent proteasomal degradation of target proteins. Promotes proteasomal degradation of COMMD1 and IKBKB. Modulates NF-kappa-B transcriptional ...more
- ENST00000316403
- ENSP00000315130
- ENSG00000120885
- ENST00000405140
- ENSP00000385419
- ENST00000523500
- ENSP00000429620
- APOJ
- CLI
- KUB1
- CLI
- AAG4
- APOJ
- CLU1
- CLU2
- KUB1
- SGP2
- APO-J
- SGP-2
- SP-40
- TRPM2
- TRPM-2
- NA1/NA2
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
biological process | 1 | ||
transcription factor perturbation | 1 | ||
virus perturbation | 0.96 | ||
PubMedID | 0.95 | ||
chemical | 0.87 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 2218.06 (req: < 5)
Gene RIFs: 475 (req: <= 3)
Antibodies: 1092 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 2218.06 (req: >= 5)
Gene RIFs: 475 (req: > 3)
Antibodies: 1092 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 57
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0